235968
Trends and Review of State Obesity Legislation, 2001-2008
Tuesday, November 1, 2011: 5:15 PM
Background: Obesity rates in the United States have been increasing for over 30 years. Currently, 33.8% of adults are obese. Objective: This study includes the review of 458 bills that were introduced over the past eight years with the expressed purpose of preventing or treating obesity. Design: Bills were obtained from state legislature websites and CDC's Division of Nutrition, Physical Activity, and Obesity legislative database. Main Outcome Measures: Bills are illustrated according to their setting or intent (School, Healthcare, Community, and Taskforce), Status, Percent success by category and type, and findings from passed bills. Results: The largest number of bills introduced was in the School category with 228, followed by Healthcare (85), Taskforce (77), and Community (68). Percentages of bills passed were: Taskforce (31%), Health Care (15%), Schools (14%), and Community (10%). Conclusion: Overall, 17% of obesity bills passed from 2001-2008. Legislation can be an important first step to change society and institutionalized norms to encourage and support people to develop healthier behaviors. Practitioners and policy-makers could find useful, the results of follow-up summaries and recommendation reports of such legislation.
Learning Areas:
Public health or related laws, regulations, standards, or guidelines
Public health or related public policy
Learning Objectives: 1. List the main sectors of focus for obesity legislation over the past 8 years.
2. Identify at least two examples of the most common obesity bills.
3. Name at least one example of a promising policy.
Keywords: Legislative, Obesity
Presenting author's disclosure statement:Qualified on the content I am responsible for because: I conducted the research for this submission
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines,
and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed
in my presentation.
|